Mitochondrially targeted p53 has tumor suppressor activities in vivo

Flaminia Talos1, Oleksi Petrenko, Patricio Mena

  • 1Department of Pathology, Stony Brook University, Stony Brook, New York 11794-869, USA.

Cancer Research
|November 4, 2005
PubMed

Insights

Targeting mitochondria with p53 triggers apoptosis in cancer cells. This novel approach shows significant tumor suppressor activity in vivo, offering potential for future cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The tumor suppressor protein p53 (also known as TP53) plays a critical role in preventing cancer through complex proapoptotic functions.
  • A novel transcription-independent mechanism of p53 involves rapid proapoptotic action at the mitochondria, representing the shortest known p53 death signaling pathway.

Purpose of the Study:

  • To investigate the potential of exploiting the p53-dependent mitochondrial apoptotic program for in vivo tumor suppression.
  • To evaluate the efficacy of targeted mitochondrial delivery of p53 in a mouse model of lymphomagenesis.

Main Methods:

  • Utilized Emu-Myc transgenic mice, a model for p53-dependent lymphomagenesis.
  • Engineered exclusive delivery of p53 to the outer mitochondrial membrane.
  • Assessed the impact on Emu-Myc-transformed B-cells and normal cells from thymus, spleen, and bone marrow.

Main Results:

  • Exclusive mitochondrial delivery of p53 significantly inhibited the proliferation of Emu-Myc-transformed B-cells from p53-deficient or alternate reading frame-deficient mice.
  • This targeted approach efficiently induced apoptosis and impinged proliferation in cancer cells.
  • Normal cells exhibited poor infectivity with the engineered viruses, indicating specificity.

Conclusions:

  • The direct mitochondrial apoptotic p53 program demonstrates significant tumor suppressor activity in vivo.
  • This proof-of-principle study supports further investigation into the therapeutic potential and safety of this novel cancer treatment strategy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...